FDA Inspection 1195721 — Seattle Reproductive Medicine, PLLC

Seattle Reproductive Medicine, PLLC — FEI 3005187125

The FDA completed an inspection of Seattle Reproductive Medicine, PLLC on January 25, 2023 in Kirkland, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 25, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Kirkland, WA (United States)